MedTrace Logo

Effects of Sprint Interval Training on Field Hockey Players.

NCT06502626 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2024-07-16

No results posted yet for this study

Summary

Field hockey is a team sport that is played using sticks and balls. Player's motions are impromptu and determine how competitive matches are played. Athletes can enhance their performance through a variety of training regimens. "Sprint Interval Training," for short bursts of maximal or supramaximal exercise, is one type of training used to improve sports performance. During recovering intervals, participants alternate between passive rest or light to moderately hard work. In both skilled and novice players, Sprint interval training significantly increases anaerobic and aerobic performance. This study aims to determine the impact of sprint interval training on hockey player's running performance, speed, and direction changes.

Conditions

  • Sports Physical Therapy

Interventions

OTHER

Regular training

performed their routine programs

OTHER

Sprint Interval Training

Sprint interval training will be given for 4 weeks. Each week consisted of three training sessions, separated by at least one resting day. Participants will complete a 15-minutes warm up before training session. The Sprint interval training group consisted of 30 s sprints at near maximal effort, with three minutes of rest between each sprint. The training intensity of Sprint interval training sessions was evaluated subjectively during sessions. During the first week, the Sprint interval training group performed five sprints per session. The number of sprints then increased gradually, until a total of 10 sprints per session. When the number of sprints reached seven, subjects were given six minutes of rest midway through the training session

Sponsors & Collaborators

  • Riphah International University

    lead OTHER

Principal Investigators

  • Amna Shahid, T-DPT · Riphah International University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-02-15
Primary Completion
2024-07-15
Completion
2024-08-25

Countries

  • Pakistan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06502626 on ClinicalTrials.gov